Approval · Notice of Compliance 36732 · 2026
IXCHIQ: Notice of Compliance 36732
Issued January 14, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36732
- Date
- January 14, 2026
- Company
- Valneva Austria GmbhVienna, Wien, Austria
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IXCHIQ | Not yet assigned | — |
Medicinal ingredients
- CHIKUNGUNYA VIRUS LIVE-ATTENUATED 3 L10T50 per 0.5ML